Customized solutions for recombinant protein production
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
12
NCT07039201
A Study to Evaluate CG-102-12C in Glypican-3 (GPC3) Positive Advanced Hepatocellular Carcinoma (HCC)
Phase: N/A
Role: Collaborator
Start: Jun 20, 2025
Completion: Jul 31, 2027
Loading map...